Cannabis Regulation: FDA, State, and Stakeholder Perspectives

March 26, 2025 | In-Person & Virtual Event

Last Year’s Agenda

A preliminary agenda will be announced in late January 2025. If you would like to be notified, please let us know.

Thursday, April 4, 2024

FDLI Welcome
Christine M. Simmon, President & CEO, FDLI

FDA Fireside Chat
Norman Birenbaum, Senior Public Health Advisor, Center for Drug Evaluation and Research (CDER), FDA
Patrick Cournoyer, Senior Science Advisor and Lead, Cannabis Products Committee, Office of the Commissioner (OC), FDA
Charlotte Conway, Deputy Director, Center for Veterinary Medicine (CVM), FDA
Cara Welch, Director, Office of Dietary Supplement Programs, Center for Food Safety and Applied Nutrition (CFSAN), FDA
Moderated by Andrew J. Kline, Senior Counsel, Perkins Coie LLP

Jonathan Havens, Partner, Saul Ewing LLP
Andrew J. Kline, Senior Counsel, Perkins Coie LLP
Sharon Linden Mayl, Partner, DLA Piper LLP
Debby Miran, Principal, DMiran Consulting
Elizabeth A. Oestreich, Senior Vice President, Regulatory Compliance, ELIQUENT Life Sciences